The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

Date
1997
Author
Ripley, R
Richards, S
Wilberforce, S
Chen, ZM
vanGijn, J
Harrison, M
Wilhelmsen, L
Warlow, C
Anderson, S
Bowie, A
Boyle, J
Brownlie, A
Charlton, D
Cranswick, G
Day, L
Dennis, M
Dorman, P
Fraser, H
Kaye, M
Lindley, R
Liu, M
MacDonald, C
McCrindle, I
Middleton, G
Perry, D
Scoltock, V
Smith, B
Taylor, H
Waddell, F
Sandercock, P
Collins, R
Counsell, C
Farrell, B
Peto, R
Slattery, J
Wardlaw, J
Crowther, J
Heineman, J
Knight, S
Radley, A
Metadata
Show full item record
Abstract
Background Only a few small trials have compared antithrombotic therapy (antiplatelet or anticoagulant agents) versus control in acute ischaemic stroke, and none has been large enough to provide reliable evidence on safety or efficacy.
URI
http://hdl.handle.net/20.500.12627/52685
https://doi.org/10.1016/s0140-6736(97)04011-7
Collections